Stabley JN, Dominguez JM 2nd, Dominguez CE, Solis FR, Ahlgren J, Behnke BJ, Muller-Delp JM, Delp MD. Spaceflight reduces vasoconstrictor responsiveness of skeletal muscle resistance arteries in mice. J Appl Physiol 113: 1439 -1445, 2012. First published September 13, 2012 doi:10.1152/japplphysiol.00772.2012.-Cardiovascular adaptations to microgravity undermine the physiological capacity to respond to orthostatic challenges upon return to terrestrial gravity. The purpose of the present study was to investigate the influence of spaceflight on vasoconstrictor and myogenic contractile properties of mouse gastrocnemius muscle resistance arteries. We hypothesized that vasoconstrictor responses acting through adrenergic receptors [norepinephrine (NE)], voltage-gated Ca 2ϩ channels (KCl), and stretch-activated (myogenic) mechanisms would be diminished following spaceflight. Feed arteries were isolated from gastrocnemius muscles, cannulated on glass micropipettes, and physiologically pressurized for in vitro experimentation. Vasoconstrictor responses to intraluminal pressure changes (0 -140 cmH 2O), KCl (10 -100 mM), and NE (10 Ϫ9 -10 Ϫ4 M) were measured in spaceflown (SF; n ϭ 11) and ground control (GC; n ϭ 11) female C57BL/6 mice. Spaceflight reduced vasoconstrictor responses to KCl and NE; myogenic vasoconstriction was unaffected. The diminished vasoconstrictor responses were associated with lower ryanodine receptor-2 (RyR-2) and ryanodine receptor-3 (RyR-3) mRNA expression, with no difference in sarcoplasmic/endoplasmic Ca 2ϩ ATPase 2 mRNA expression. Vessel wall thickness and maximal intraluminal diameter were unaffected by spaceflight. The data indicate a deficit in intracellular calcium release via RyR-2 and RyR-3 in smooth muscle cells as the mechanism of reduced contractile activity in skeletal muscle after spaceflight. Furthermore, the results suggest that impaired end-organ vasoconstrictor responsiveness of skeletal muscle resistance arteries contributes to lower peripheral vascular resistance and less tolerance of orthostatic stress in humans after spaceflight. spaceflight; microgravity; vasoconstriction; skeletal muscle; c57bl/6 mice; orthostatic intolerance THE CARDIOVASCULAR CONSEQUENCES of microgravity exposure are evident in the form of orthostatic intolerance (3, 29, 50), reduced aerobic exercise capacity (19, 40, 50) , elevated heart rate (50), and hypovolemia (31, 50). In particular, up to 64% of astronauts experience orthostatic intolerance after only 2 wk of spaceflight (5), whereas habitation in a microgravity environment for several months or more results in virtually all astronauts experiencing orthostatic intolerance upon return to Earth (26). Early work in humans (5, 29) established that orthostatic intolerance was principally the result of the reduced capacity to elevate peripheral vascular resistance following spaceflight.
Microgravity-induced adaptations in the vasculature were consequently hypothesized to be a primary underlying mechanism to reduced peripheral vascular resistance after the contributions from the baroreflex (19) , hypovolemia, and reduced cardiac chamber volume were shown to be less pronounced (5, 50) . One vascular bed that may be important for understanding microgravity-induced orthostatic hypotension is the skeletal muscle, from which ϳ40% of the increase in total peripheral vascular resistance comes from the skin and skeletal muscle upon standing (39) .
Human cardiovascular adaptations to relative disuse (i.e., bed rest or microgravity) are well replicated in rat (12, 25, 38) and, more recently, mouse (36) models to simulate microgravity via hindlimb unloading (HU). The HU rodent model effectively induces an array of cardiovascular changes that occur with humans in microgravity, including a cephalic fluid shift (7, 18, 23, 37, 51) , hypovolemia (37, 41) , resting and exercise tachycardia (25) , postural muscle unloading (25, 30) , and decreased aerobic exercise capacity (13, 34, 36) . Previous work utilizing a terrestrial HU intervention in the rat has provided mechanistic insight into orthostatic hypotension following disuse (23, 51) . For instance, impairment of vasoconstrictor properties in muscle composed predominantly of fast-twitch fibers, such as resistance arteries from gastrocnemius muscle (10) , was associated with reductions in medial wall thickness and medial cross-sectional area of feed arteries and first-order arterioles after 2 wk of HU in rats (11) ; separate experiments ruled out an enhanced vasodilator responsiveness (21, 24) in these resistance arteries. Resistance arteries in muscle composed predominantly of slow-twitch fibers, such as the soleus muscle, did not exhibit alterations in vasoconstrictor function in HU rats (10) . The decrements in vasoconstrictor responsiveness (10) and the vascular remodeling (i.e., thinning of smooth muscle medial layer) (11) in fast-twitch skeletal muscle were thought to be associated with the headward fluid shift and the lowering of arterial blood pressure in the hindlimbs (7) during this microgravity simulation. The purpose of the present investigation was to determine whether actual spaceflight impairs vasoconstrictor and myogenic responsiveness or induces changes in gross vascular structure of mouse gastrocnemius muscle feed arteries, which are a major source of vascular resistance in skeletal muscle (53) . We hypothesized that vasoconstrictor responses acting through receptor (NE), voltage-gated Ca 2ϩ channel (KCl), and stretch-activated (myogenic) mechanisms would be diminished and that the decrement in vasoconstrictor responsiveness would be associated with a thinning of the medial smooth muscle cell layer of the arterial wall (10, 11).
MATERIALS AND METHODS
Experimental procedures were approved by the Institutional and Animal Care and Use Committee at the National Aeronautics and Space Administration (NASA) and conformed to the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH publication no. 85-23, revised 1996) .
Animals. Eleven female C57BL/6 mice (16 -23 wk old) were flown for 15 days on NASA's STS-131 space shuttle mission. Mice were housed in NASA's animal enclosure modules (AEMs) located on the orbiter's middeck, maintained on a 12:12-h light-dark cycle and provided food (46) and water ad libitum. Eleven ground control (GC) animals (11-23 wk old) were housed in identical AEMs within an orbital environment simulator at Kennedy Space Center (KSC) to mimic the temperature, humidity, and CO 2 levels of the space shuttle middeck. GC animals were housed for the duration of the STS-131 mission in the orbital environment simulator beginning 48 h after launch and ending 48 h after landing, at which point all experimental procedures conducted on the spaceflight (SF) animals were duplicated on GC animals. The KSC veterinarian deemed all animals healthy before SF and GC experiments.
Microvessel preparation. Approximately 2.5 h after the landing of the space shuttle, the mice were anesthetized with 5% isoflurane inhalation and euthanized by thoracotomy and exsanguination. Hindlimb muscles were excised from the carcass, and their mass was measured on a laboratory balance. Gastrocnemius muscle feed arteries were dissected free via dissecting microscope (Olympus SZX12) and maintained in physiological saline buffer solution (PSS) on ice. During ongoing dissection procedures, microvessel tissue was transferred in a staggered fashion from KSC to the University of Florida's campus in Gainesville, FL (ϳ3-h drive) to facilitate the physiological experiments. Feed arteries were transferred to a Lucite chamber containing PSS. Microvessels were cannulated at each end with glass micropipettes, secured via 11-0 ophthalmic suture (Alcon Laboratories, Fort Worth, TX), and pressurized with PSS. After cannulation, the isolated vessel tissue chamber was transferred to the stage of an inverted microscope (Olympus IX70) interfaced in series with a video camera (Panasonic BG310), a horizontal video caliper (307A, Colorado Video, Boulder, Colorado), a data-acquisition system (Powerlab, ADInstruments, Colorado Springs), and a video monitor (Panasonic WV-BM1410). Vessels were equilibrated at 37°C and 90 cmH2O intraluminal pressure (53) for 15 min before investigation of vasoconstrictor and myogenic properties. Bathing PSS was replaced every 15 min during equilibration and throughout the experimental procedures. Intraluminal diameters were continuously measured by videomicroscopic techniques (10, 11, 16, 21, 24) .
Experimental design. Intraluminal pressure was maintained and manipulated by way of two independent reservoirs connected to the glass micropipettes cannulating the feed arteries. Basal pressure (i.e., 90 cmH2O) was achieved by setting both reservoirs at the same hydrostatic level. First, vasoconstrictor responses to increasing concentrations of KCl (10 -100 mM) were measured to investigate the contribution of voltage-gated Ca 2ϩ channels. Target isotonic K ϩ bath concentrations were achieved by balancing concentrations of NaCl and KCl in PSS such that bath osmolarity was maintained (14) . Second, active myogenic behavior was determined via stepwise increases in intraluminal pressure (i.e., from 0 to 140 cmH2O) by raising the height of both reservoirs in 20-cmH2O increments. Intraluminal pressure was then decreased in 20-cmH2O increments from 140 to 60 cmH2O (10) . Third, vasoconstrictor responses to the cumulative addition of NE (10 Ϫ9 -10 Ϫ4 M) were measured to investigate the contribution of alpha adrenoreceptors (10) . Finally, maximal intraluminal diameter and medial wall thickness were determined after two 15-min incubations in Ca 2ϩ -free PSS at 90 cmH2O. A bolus dose of sodium nitroprusside (10 Ϫ4 M) (11, 24) was added during the second 15-min incubation in Ca 2ϩ -free PSS to ensure complete vessel relaxation. Medial wall thickness was taken as the mean of three separate wall thickness measurements from positions randomly selected along the microvessel length. To measure medial wall thickness, the video caliper used to measure intraluminal diameter was positioned on the far right or far left side of the vessel. The focal plane was adjusted through the medial wall, and the smallest distance between the inner and outer surface was taken to be medial wall thickness. Variability among the three measures of wall thickness for each feed artery was ϳ9% (range 0 -15%) in GC mice and 8% (range 0 -13%) in SF animals.
In a second set of gastrocnemius muscle feed arteries, the passive pressure-diameter relation was determined using a similar protocol as that for determining the active myogenic response. Vessels were exposed to two 15-min incubations in Ca 2ϩ -free PSS. During the second 15-min incubation, sodium nitroprusside (10 Ϫ4 M) was added to the Ca 2ϩ -free PSS to ensure complete vessel relaxation. Intraluminal pressure was increased in a stepwise fashion from 0 to 140 cmH2O and then lowered from 140 to 60 cmH2O in 20-cmH2O increments. Maximal intraluminal diameter and medial wall thickness at 90 cmH2O were then determined as described above. Reported values for maximal intraluminal diameter and medial wall thickness were derived from the averages of the two sets of vessels measured from each animal.
mRNA. Gastrocnemius muscle feed arteries of similar length were isolated from SF and GC mice and were snap frozen and stored at Ϫ80°C for later analysis of mRNA expression as previously described (6, 14, 42) . The RNAqueous-Micro Kit (Applied Biosystems/Ambion, Austin, TX), specified for use in microdissected tissue, was used to isolate total RNA from feed arteries. Vessels immersed in 100 l of lysis buffer were homogenized using a pellet mixer (Argos Technologies, Elgin, IL). The lysate solution was then passed through the RNAqueous silica filter for total RNA isolation. Total RNA was reverse transcribed into complimentary DNA (cDNA) via the highcapacity cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA). Five microliters of cDNA was then used for real-time PCR (StepOnePlus, Applied Biosystems, Carlsbad, CA) to determine mRNA expression by way of TaqMan Gene Expression Assays (Applied Biosystems, Carlsbad, CA) specific for sarcoplasmic reticulum Ca 2ϩ -ATPase pump 2b (SERCA2b; Mm01201431_m1), ryanodine receptor 2 (RyR-2; Mm00465877_m1), and ryanodine receptor 3 (RyR-3; Mm01328421_m1). On the basis of data from a previous study where no ryanodine receptor 1 mRNA expression was detected in rat mesenteric arteries (6), we elected only to probe for changes in RyR-2 and RyR-3 mRNA expression.
Solutions and drugs. PSS buffer contained (in mM) 145 NaCl, 4.7 KCl, 1.2 NaH 2PO4, 1.17 MgSO4, 2.0 CaCl2, 5.0 glucose, 2.0 pyruvate, 0.02 EDTA, and 3.0 MOPS with a pH of 7.4. PSS was supplemented with bovine serum albumin (BSA; 1 g/100 ml; USB, Cleveland, OH) and passed through a 0.22-m cellulose acetate filter (430015, Corning, New York). Ca 2ϩ -free PSS buffer preparation was identical except for the addition of 2 mM EDTA, the replacement of CaCl2 with 2.0 mM NaCl, and the exclusion of BSA. KCl and NE stock solutions were prepared in PSS buffer.
Statistical and data analysis. Intraluminal diameters were measured in micrometers and expressed as a percentage of vasoconstriction as follows
where D b was the initial baseline intraluminal diameter measured before experimental intervention and Ds was the steady-state intraluminal diameter measured after agonist addition.
Spontaneous tone was expressed as a percentage of the maximal diameter (D m) as follows
The significance of differences in body mass and muscle tissue mass were determined via Student's unpaired t-tests. Pressure-re-sponse and concentration-response curves were evaluated by using repeated-measures ANOVA with one within (intraluminal pressure or agonist concentration) and one between (experimental groups) factor. Planned contrasts were conducted at each intraluminal pressure or concentration level to determine whether differences existed between experimental groups (GC vs. SF). All values presented are means Ϯ SE. An alpha level of 0.05 delineated significance.
RESULTS
Body and tissue mass. Total body mass tended to be lower in SF (n ϭ 11) vs. GC (n ϭ 11) mice (SF, 20.85 Ϯ 0.65 g; GC, 22.03 Ϯ 0.44 g; P ϭ 0.07). Gastrocnemius muscle mass was 7-13% lower in SF mice (Table 1) .
Vessel structure. Medial wall thickness (SF: 16 Ϯ 1; GC: 14 Ϯ 1 m) and maximal diameter (SF: 175 Ϯ 7; GC: 188 Ϯ 5 m) at 90 cmH 2 O were not different between groups (n ϭ 11 for each group).
Spontaneous tone. Steady-state spontaneous tone measured before the KCl dose response (SF: 21 Ϯ 6%; GC: 19 Ϯ 3%), the NE dose response (SF: 17 Ϯ 6%; GC: 22 Ϯ 6%), and the myogenic pressure-diameter response (SF: 21 Ϯ 5%; GC: 20 Ϯ 5%) was not different (P ϭ 0.951) between groups (n ϭ 11 for each group).
Vasoconstrictor responses. Vasoconstriction in response to the cumulative addition of NE was lower in gastrocnemius feed arteries of SF mice compared with their GC counterparts (Fig. 1) . Spaceflight also reduced vasoconstriction in response to isotonic KCl relative to GC mice (Fig. 2) .
Active and passive pressure-diameter responses. Active myogenic responses were not different between gastrocnemius feed arteries from SF and GC mice (Fig. 3) . Likewise, passive pressure-diameter responses were not different between groups (Fig. 4) .
mRNA expression. SERCA2b mRNA expression was not different between groups (Fig. 5A) . However, both RyR-2 and RyR-3 mRNA expression were lower in SF mice relative to that in GC mice (Fig. 5, B and C) .
DISCUSSION
The purpose of this study was to determine whether microgravity exposure alters the intrinsic vasoconstrictor and myogenic responsiveness or gross vascular structure of gastrocnemius muscle resistance arteries in mice. Based on previous ground-based studies to simulate microgravity in HU rats, we hypothesized that vasoconstrictor responses acting through receptor (NE), voltage-gated Ca 2ϩ channel (KCl), and stretchactivated (myogenic) mechanisms would be diminished and that the decrement in vasoconstrictor responsiveness would be associated with a thinning of the medial smooth muscle cell layer of the arterial wall (10, 11 ). The results demonstrate that microgravity exposure decreases vasoconstrictor responses elicited through alpha-adrenergic receptors (Fig. 1) and voltage-gated Ca 2ϩ channels (Fig. 2) but did not affect myogenic vasoconstrictor responsiveness (Fig. 3) . Spaceflight also re- †Space flown mice different from ground control mice (P ϭ 0.09). duced the expression of RyR-2 ( Fig. 5B ) and RyR-3 ( Fig. 5C ) mRNA. Microgravity did not alter the gross structure or passive mechanical properties of gastrocnemius muscle resistance arteries, as evidenced by the lack of change in both medial wall thickness and maximal intraluminal diameter, as well as the passive pressure-diameter response (Fig. 4) after spaceflight. If applicable to the human condition, these results suggest that microgravity-induced changes in the vasoconstrictor characteristics of skeletal muscle resistance arteries could compromise the ability to elevate peripheral vascular resistance and precisely regulate mean arterial pressure during an orthostatic challenge. A variety of discrete vasoconstrictor stimuli were administered to elucidate potential mechanisms of reduced vasoconstriction after spaceflight. NE and KCl cause vasoconstriction through both the influx of extracellular Ca 2ϩ and efflux of intracellular Ca 2ϩ from the sarcoplasmic reticulum (4, 8, 43) . In contrast, myogenic vasoconstriction in response to elevations in transmural pressure is more dependent on extracellular -2; B) , and ryanodine receptor-3 (RyR-3; C) mRNA expression in gastrocnemius feed arteries. Values are means Ϯ SE. N equals the number of animals studied. *Spaceflight group mean (n ϭ 10) is significantly different from ground control group mean (n ϭ 9; P Ͻ 0.05).
Ca
2ϩ for smooth muscle contraction (27, 47) . For example, although several studies indicate that mobilization of intracellular Ca 2ϩ stores may occur in the myogenic response (9, 32), release of intracellular Ca 2ϩ is not essential for myogenic vasoconstriction of resistance arteries (48, 49) . Therefore, the differential effects of spaceflight to impair vasoconstriction to NE and KCl, but not to increasing transmural pressure, likely reflect the different sources of Ca 2ϩ recruited for the respective smooth muscle contractions. These findings suggest that microgravity adversely affects smooth muscle cell cytosolic Ca 2ϩ control through an intracellular mechanism, i.e., either through an impaired sarcoplasmic reticulum Ca 2ϩ release mechanism or an enhanced sarcoplasmic reticulum Ca 2ϩ pump mechanism. To test this possibility, RyR-2 and RyR-3 mRNA, the ryanodine receptor isoforms present in smooth muscle (22, 33) , and sarcoplasmic reticulum Ca 2ϩ ATPase (SERCA2b) (54) mRNA expression were measured in the gastrocnemius muscle feed arteries. RyR-2 and RyR-3 expression were lower in skeletal muscle resistance arteries from SF mice (Fig. 5 , B and C), whereas SERCA2b expression was not different between groups (Fig. 5A) . These data implicate RyR-2 and RyR-3 alterations in reducing intracellular Ca 2ϩ release and diminishing smooth muscle contractile responsiveness to NE and KCl.
The findings of microgravity-induced impairment of vascular smooth muscle contraction via an intracellular Ca 2ϩ release mechanism are consistent with those of several ground-based studies of HU rats designed to simulate spaceflight. Morel and coworkers (28) found lower intracellular Ca 2ϩ release in response to NE, angiotensin II, and caffeine in rat portal vein myocytes after 14 days of HU. Furthermore, [ 3 H]ryanodine binding in the same myocytes revealed a reduction in sarcoplasmic reticulum-based ryanodine receptors in the presence of unaltered ryanodine receptor Ca 2ϩ sensitivity and unaltered voltage-gated Ca 2ϩ channel activity (28). Colleran et al. (6) also demonstrated a reduction in NE-, KCl-, and caffeineinduced vasoconstriction of mesenteric resistance arteries, as well as decreased RyR-2 mRNA and protein expression after 14 days of HU. These investigators reported no change in SERCA2b mRNA expression in mesenteric vascular smooth muscle after HU (6), therefore obviating a role for Ca 2ϩ sequestration in reducing intracellular Ca 2ϩ concentration. Spaceflight did not alter medial wall thickness or maximal diameter of gastrocnemius muscle resistance arteries. However, unlike the present results, previous studies simulating microgravity with HU rats have shown reduced medial wall thickness and medial cross-sectional area with no change in maximal diameter of gastrocnemius muscle feed arteries and first-order arterioles (10, 11) . These disparate effects of actual vs. simulated microgravity appear to have functional consequences on vasoconstrictor properties. For instance, neither the active and passive pressure-diameter relations nor the vascular morphological characteristics are different between SF and GC mice in the present study (Figs. 3 and 4) . On the other hand, the decrease in medial wall thickness in HU rats (11) is associated with a reduction in active myogenic vasoconstriction and an increase in vascular distensibility in the passive pressurediameter relation (10) . The reason for the different effects of actual and simulated microgravity on remodeling of the vessel wall is unknown but could reflect differences in the animal species studied and the extent to which fluid pressure shifts under these conditions. With HU, for example, general cardiovascular adaptations (i.e., resting tachycardia and reduced exercise capacity) appear equivalent between rats (13, 25, 34) and mice (36) . However, the significantly shorter body height of the mouse may fail to form a graduated hydrostatic column whose pressure gradients can be sufficiently altered in microgravity to contribute to the type of vascular remodeling observed in HU rats. Whereas rats experience cephalic fluid pressure shifts with HU (7, 18, 23, 37) , the relative short body length and height of mice may prevent changes of similar magnitude in blood volume distribution during microgravity exposure.
To understand the impact that alterations in fluid pressure gradients have on vascular structure, one can examine how headward fluid pressure shifts differentially induce regional vascular remodeling. In HU rats, arterial pressure to the head increases by ϳ15-24 mmHg (7, 52) ; this increase in arterial pressure is accompanied by a thickening of the medial layer of cerebral arteries (17, 51, 52, 55) . Conversely, in the hindlimb of HU rats, arterial pressure decreases ϳ11 mmHg (7) and is associated with a thinning of the medial layer in gastrocnemius muscle resistance arteries (11) . Resistance arteries at or near the hydrostatic indifference point of HU rats, such as mesenteric arteries, do not demonstrate any remodeling of gross vascular structure (2, 6, 35, 52) . The lack of change in gross structure of the gastrocnemius muscle feed artery from mice flown on the space shuttle suggests that mice, unlike humans (50), do not experience significant fluid pressure shifts while in space. This putative absence of a fluid pressure shift undermines the utility of mice as a research model for the study of gravitational stress on humans. However, despite this shortcoming, results from the present study demonstrate that spaceflight has adverse effects on the vasoconstrictor properties of skeletal muscle resistance arteries, similar to vessels such as the mesenteric arteries located at or near the hydrostatic indifference point in HU rats (2, 6, 12, 35) and rats flown on the space shuttle (20) , which have no change in gross vascular structure but impaired vasoconstrictor responsiveness.
As mentioned above, neither spaceflight with mice nor HU of rats altered maximal diameter of gastrocnemius muscle resistance arteries. This lack of change in vessel diameter likely reflects preserved blood flow to the portion of the gastrocnemius muscle perfused through this feed artery during muscle unloading (10, 11, 25) . Had the resistance vasculature of a tonically active skeletal muscle been examined, such as that of the soleus muscle, we would expect a decrease in muscle perfusion with microgravity-induced weightlessness (25) and a corresponding decrease in maximal diameter of feed arteries and arterioles (10, 11) .
Impairment of vasoconstrictor responsiveness of skeletal muscle resistance arteries may underlie, at least in part, the reduced orthostatic tolerance evident in humans following spaceflight (5, 29, 50) , given that ϳ40% of the increase in total peripheral vascular resistance comes from the skin and skeletal muscle upon standing (39) . Therefore, strategies to counteract this deleterious consequence of microgravity exposure are important for preserving functional capacity and orthostatic tolerance following long-term spaceflight in humans. The condition of orthostatic intolerance is usually corrected within 2 days of return to terrestrial gravity, whereas complete orthostatic recovery is achieved in a length of time equivalent to that of flight operations (50) . Recovery of orthostatic tolerance is achieved even after several months of microgravity exposure (1) . Swift adaptation to orthostasis upon return to terrestrial gravity clearly involves compensatory adjustments in the autonomic nervous system (15) and blood volume (19, 44, 45) . Given the present results, characterization of the time course of the purported recovery of vasoconstrictor responsiveness after spaceflight requires further in vitro investigation to better understand the extent of its contribution to the recovery of orthostatic tolerance.
In conclusion, responses to agonist-induced stimulation of both receptor-(NE; Fig. 1 ) and nonreceptor (KCl; Fig. 2 )-mediated vasoconstriction were reduced after 15 days of spaceflight in gastrocnemius muscle resistance arteries. However, myogenic vasoconstrictor responsiveness was unaffected by microgravity exposure (Fig. 3) , suggesting that the hyporesponsiveness of agonist-induced vasoconstriction may be mediated through an impaired sarcoplasmic reticulum Ca 2ϩ release mechanism. In support of this contention, both RyR-2 and RyR-3 mRNA expression were lower in gastrocnemius muscle resistance arteries from spaceflown mice (Fig. 5, B and C). Although these data support the hypothesis that impaired vasoconstrictor responsiveness of skeletal muscle resistance arteries contributes to the relative inability of astronauts to elevate peripheral vascular resistance after spaceflight, the mouse may not be an ideal animal model to study this phenomenon. The lack of gross structural remodeling or, more specifically, the lack of change in medial wall thickness suggests that blood volume redistribution is insignificant in this animal during spaceflight. This is an important shortcoming in our attempts to understand the effects of microgravity exposure on human cardiovascular function.
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